Partners
Partners

Partner 36 - ANGLE PLC


 

 

Michael O´Brien

 

Head of Business Development

Europe

 

undefinedE-Mail

 

 

ANGLE PLC

 

3 Frederick Sanger Road

GU2 7YD

UK

 

undefinedWebsite

CANCER-ID Team ANGLE Europe

Dr. Lara Stevanato

 

Lead Scientist

 

 

undefinedE-Mail

 

 

Dr. Arianna Hustler

 

Scientist

 

 

 

 

Company presentation

ANGLE is a UK and US based medical diagnostics company. ANGLE has developed the Parsortix CTC capture and harvest system for the enrichment of circulating tumor cells from blood. The system captures CTCs on the basis of their larger size and lower compressibility than other blood components. This approach avoids a bias that can be introduced when cells are captured on the basis of antigen expression. Importantly, the system can deliver highly enriched and viable CTCs in solution, ready to be used for a range of downstream molecular and functional analysis.

 

ANGLE has initiated two 200 patient clinical studies in Europe and the US for the Company’s first clinical application for detection of ovarian cancer in women with a high risk pelvic mass. Furthermore, following successful pilot studies, ANGLE is assessing the potential to develop additional clinical applications in metastatic breast cancer and prostate cancer.

 

 

CANCER-ID Consortium

CANCER-ID consortium

CANCER-ID Workpackages

CANCER-ID Work Plan

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

developed by TATAA Biocenter and the Institute of Biotechnology, BIOCEV. Read more

Social Media

LinkedIn Cancer-ID